In Southeast Asia, 36 percent of the drug samples tested were judged to be counterfeit, as were 20 percent of the drug samples in sub - Saharan Africa.
Di Asia Tenggara, 36 persen dari sampel obat yang diuji dinyatakan gadungan, begitu juga 20 persen dari sampel obat di sub - Sahara Afrika.